Perlecan domain IV peptide stimulates salivary gland cell assembly in vitro.
Treatment of xerostomia would benefit from development of a functional implantable artificial salivary gland. Salivary gland tissue from surgical patients was assessed by histology and immunohistochemistry to establish the phenotype of normal salivary gland cells including the native basement membranes. Ductal and acinar cells were identified in tissue and cultured cells from dispersed tissue. High levels of laminin and perlecan/HSPG2 (heparan sulfate proteoglycan 2) were noted in basement membranes, and perlecan also was secreted and organized by cultured acinar populations, which formed lobular structures that mimicked intact glands when cultured on Matrigel or a bioactive peptide derived from domain IV of perlecan. On either matrix, large acini-like lobular structures grew and formed connections between the lobes. alpha-Amylase secretion was confirmed by staining and activity assay. Biomarkers, including tight junction protein E-cadherin and water channel protein aquaporin 5 found in tissue, were expressed in cultured acinar cells. Cells cultured on Matrigel or domain IV of perlecan peptide organized stress fibers and activated focal adhesion kinase. We report a novel technique to isolate acinar cells from human salivary gland and identify a human peptide sequence in perlecan that triggers differentiation of salivary gland cells into self-assembling acini-like structures that express essential biomarkers and which secrete alpha-amylase.
Pradhan
Swati
S
Department of Biological Sciences, University of Delaware, Newark, Delaware, USA.
Zhang
Chu
C
Jia
Xinqiao
X
Carson
Daniel D
DD
Witt
Robert
R
Farach-Carson
Mary C
MC
D002454:Cell Differentiation / Q000187:drug effects; D049109:Cell Proliferation / Q000187:drug effects; D002478:Cells, Cultured; D019812:Heparan Sulfate Proteoglycans / Q000008:administration & dosage*; D006801:Humans; D017434:Protein Structure, Tertiary; D012469:Salivary Glands / Q000166:cytology* / Q000187:drug effects / Q000254:growth & development*; D023822:Tissue Engineering / Q000379:methods*
D019812:Heparan Sulfate Proteoglycans; C071927:perlecan